Lexeo Therapeutics Newsroom

Baird Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsNov 21 02:31 ET

RBC Capital Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsNov 14 21:32 ET

Lexeo Therapeutics, Inc. (LXEO) Gets a Buy From RBC Capital

TipRanksNov 14 20:51 ET

Promising Developments in Lexeo Therapeutics' LX2006 Program Drive Buy Rating

TipRanksNov 14 06:31 ET

H.C. Wainwright Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Raises Target Price to $23

Moomoo NewsNov 14 06:31 ET

Chardan Capital Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Raises Target Price to $25

Moomoo NewsNov 13 13:32 ET

Lexeo Therapeutics Is Maintained at Outperform by Leerink Partners

Dow JonesNov 13 13:10 ET

Lexeo Therapeutics Analyst Ratings

BenzingaNov 13 13:00 ET

Leerink Partners Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Announces Target Price $19

Moomoo NewsNov 13 11:31 ET

H.C. Wainwright Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsOct 31 06:35 ET

Chardan Capital Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsOct 30 10:33 ET

Lexeo Therapeutics Analyst Ratings

BenzingaOct 25 15:25 ET

Chardan Capital Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsOct 24 23:31 ET

Lexeo Therapeutics: Promising Alzheimer's Treatment Advances Drive Buy Rating

TipRanksOct 24 22:59 ET

Stifel Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsOct 10 08:31 ET

Lexeo Therapeutics, Inc. (LXEO) Receives a Buy From Stifel Nicolaus

TipRanksOct 10 07:39 ET

Chardan Capital Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsAug 14 02:32 ET

Buy Rating for Lexeo Therapeutics Backed by Strong Finances and Promising Clinical Trials

TipRanksAug 13 21:35 ET

Lexeo Therapeutics Price Target Cut to $21.00/Share From $22.00 by HC Wainwright & Co.

Dow JonesAug 13 14:33 ET

Lexeo Therapeutics Analyst Ratings

BenzingaAug 13 12:44 ET